Glucotrack, Inc. current report, 09 April 2013

SEC Filing Summary: Integrity Applications, Inc. (Form 8-K)

Business Context and Reporting Period

This Form 8-K was filed by Integrity Applications, Inc. (not Glucotrack, Inc.) on April 9, 2013. The company is incorporated in Delaware with principal executive offices in Ashkelon, Israel. The report covers events occurring on April 9, 2013.

Key Financial Metrics

The filing does not provide specific financial statements, revenue, profit, cash flow, margin, debt, or liquidity metrics. The only financial transaction disclosed is the closing of a sale of 6,300 Units, consisting of Series A 5% Convertible Preferred Stock and Warrants to purchase Common Stock. The total proceeds or valuation of this sale are not stated in the text.

Material Changes

  • Stock Quotation: The Company's common stock began public quotation on the OTC Bulletin Board under the symbol "IGAP".
  • Capital Raise: The Company closed a previously disclosed sale of 6,300 Units (Series A 5% Convertible Preferred Stock and Warrants).

Guidance, Outlook, and Risks

The filing contains no management commentary, forward-looking guidance, or specific risk factors beyond the standard disclosure of the stock listing and capital transaction. No unusual items or contingencies are described in the text provided.

Investor Verification Checklist

  • Verify the exact terms and total proceeds of the 6,300 Unit sale (Series A Preferred and Warrants) referenced in the press release (Exhibit 99.1).
  • Confirm the trading volume and liquidity of the stock under the new symbol "IGAP" on the OTC Bulletin Board.
  • Review the full press release (Exhibit 99.1) for details on the use of proceeds and the specific rights attached to the Series A Convertible Preferred Stock.
  • Clarify the relationship between the registrant "Integrity Applications, Inc." and the requested company name "Glucotrack, Inc." as they appear to be different entities.